+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Urinary Incontinence Device Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 136 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5820320

The prevalence of urinary incontinence among older women has been reported in different studies, with an overall prevalence of 14% in the US, 37% in Europe, 13% in Asia, 45.3% in Africa 45.3%, and 52% in the Middle East

The Global Urinary Incontinence Device Market is estimated to be USD 3.47 Bn in 2023 and is expected to reach USD 5.63 Bn by 2028 growing at a CAGR of 10.18%.

Urinary incontinence is a common medical condition that affects millions of people worldwide. It can cause significant physical, emotional, and social distress, leading to reduced quality of life. Urinary incontinence devices are designed to manage the symptoms of this condition, providing patients with greater independence and a better quality of life.

One of the primary drivers of the global urinary incontinence device market is the increase in the aging population. As individuals age, their bodies undergo a range of physiological changes that can affect the urinary system. These changes can include decreased bladder capacity, weakened pelvic floor muscles, and decreased kidney function. As a result, the risk of urological disorders, including urinary incontinence, increases. According to the National Institute of Diabetes and Digestive and Kidney Diseases, approximately one-third of adults aged 65 and older experience urinary incontinence.

Despite the drivers, the market also faces several restraints, with post-operative complications associated with the devices being a significant factor. While urinary incontinence devices can be effective in managing the symptoms of urinary incontinence, they are not without risks. Some of the possible complications associated with urinary incontinence devices include infection, urinary tract damage, bladder spasms, device malfunctions, and others. These complications can lead to further health complications and, in some cases, may require additional surgery.

In addition, Opportunities exist in the market for companies that invest in technological advancements in urinary incontinence devices. Smart devices, such as pelvic floor exercisers and electrical stimulation devices, can help individuals with urinary incontinence without the need for surgery. These devices provide patients with a non-invasive alternative to traditional treatments and offer a high degree of effectiveness. In addition, there is a growing demand for urethral slings, a type of implantable device that is designed to treat urinary incontinence and other urological disorders.
  • However, the market also faces significant challenges, including limited awareness and social stigma associated with the disease. Many people who suffer from urinary incontinence may not seek medical care due to embarrassment or fear of being stigmatized. This lack of awareness can lead to delays in seeking medical care, misdiagnosis, and inadequate treatment. Additionally, the social stigma associated with urinary incontinence can make it difficult for individuals to talk openly about their condition and seek help.

Market Segmentations

  • The Global Urinary Incontinence Device Market is segmented based on Product, Category, Incontinence Type, End-Users, and Geography.
  • By Product, the market is classified into Urinary Catheters, Foley Catheters, Vaginal Slings, Electrical Stimulation Devices, and Artificial Urinary Sphincters. The urinary catheter segment is considered to be the largest segment of the urinary incontinence devices market because urinary catheters are commonly used for a variety of medical conditions, including urinary incontinence. These devices are used to manage urinary retention, empty the bladder during surgery, and for patients who are unable to urinate on their own.
  • By Category, the market is classified into External Urinary Incontinence Devices and Internal Urinary Incontinence Devices. External Urinary Incontinence Devices hold the largest market share. External urinary incontinence devices such as urine collection bags or leg bags are generally used more frequently than internal urinary incontinence devices. External urinary incontinence devices are easy to use, non-invasive, and can be easily adapted to different lifestyles. They are often preferred by patients who are bedridden, have mobility issues, or have limited dexterity.
  • By Incontinence Type, the market is classified into Stress Urinary Incontinence, Urge Urinary Incontinence, Overflow Urinary Incontinence, and Functional Urinary Incontinence. Stress urinary incontinence has the largest market. The stress urinary incontinence segment accounted for the largest share. It is the most common type of urinary incontinence, accounting for approximately half of all cases. SUI occurs when the pelvic floor muscles, which support the bladder and urethra, are weakened or damaged, leading to involuntary urine leakage during physical activities such as coughing, sneezing, laughing, or exercising.
  • By End-Users, the market is classified into Hospitals, Clinics, and Others. The hospital segment holds the largest market share in the urinary incontinence devices market. It is the primary point of care for patients suffering from urinary incontinence, and they play a critical role in the diagnosis, treatment, and management of this condition. Hospitals offer a wide range of diagnostic and treatment options for urinary incontinence, including urodynamic testing, pelvic floor therapy, and surgical procedures such as slings and sphincter implants.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific. The Americas currently dominated the market. The market in the Americas is majorly driven by the increasing prevalence of Urinary Incontinence, large number of older populations, and surging demand for home care setting treatment. In addition, the APAC is estimated to grow on the highest CAGR due to its increasing population and growth in disposable income.

Recent Development

1. ProvenMed, a UAE-Based MedTech provider, entered into partnership with Gulf Medical Company, Ltd. a medical devices and healthcare solutions distribution, to provide and distribute the world’s first infection-preventative urinary incontinence management medical device, ActivGo® for men, throughout the Kingdom of Saudi Arabia (KSA). - Feb 2023
2. The prescription leva Pelvic Health System (Renovia) is the first device to offer a digital therapeutic therapy for pelvic floor muscle training to improve symptoms of urinary incontinence and fecal incontinence. - March 2023

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are, B Braun Melsungen Ag, Becton, Dickinson and Company, Caldera Medical, Inc., ConvaTec Group PLC, Teleflex, Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Nigeria, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Urinary Incontinence Device Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Urinary Incontinence Device Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Urinary Incontinence Device Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
  • Excel data sheet for the market size will also be provided with the report.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
  • The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors.
  • The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
  • Market segmentation
  • Competitive Analysis: Comparative analysis of competitor
  • Historical, current, and projected size of the market based on value and volume
  • Market size of the US states
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Impact Analysis
4.2 Drivers
4.2.1 Increase in Aging Population Coupled with High Risk of Urological Disorders
4.2.2 Rise In Shift from Conventional Solutions to Novel Urinary Incontinent Products
4.3 Restraints
4.3.1 Post-Operative Complications Associated with the Devices
4.4 Opportunities
4.4.1 Increasing Technological Advancements in Urinary Incontinence Devices
4.4.2 Growing Demand for Urethral Slings
4.5 Challenges
4.5.1 Limited Awareness and Social Stigma Associated with the Disease
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Ansoff Matrix Analysis
6 Global Urinary Incontinence Device Market, By Product
6.1 Introduction
6.2 Urinary Catheters
6.3 Foley Catheters
6.4 Vaginal Slings
6.4.1 Conventional Vaginal Slings
6.4.2 Advanced Vaginal Slings
6.5 Electrical Stimulation Devices
6.6 Artificial Urinary Sphincters
7 Global Urinary Incontinence Device Market, By Category
7.1 Introduction
7.2 External Urinary Incontinence Devices
7.3 Internal Urinary Incontinence Devices
8 Global Urinary Incontinence Device Market, By Incontinence Type
8.1 Introduction
8.2 Stress Urinary Incontinence
8.3 Urge Urinary Incontinence
8.4 Overflow Urinary Incontinence
8.5 Functional Urinary Incontinence
9 Global Urinary Incontinence Device Market, By End-Users
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Others (Home Care Settings and Ambulatory Surgical Centers)
10 Americas' Urinary Incontinence Device Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas
11 Europe's Urinary Incontinence Device Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Ireland
11.9 Italy
11.10 Luxembourg
11.11 Netherlands
11.12 Norway
11.13 Poland
11.14 Russia
11.15 Spain
11.16 Sweden
11.17 Switzerland
11.18 United Kingdom
11.19 Rest of Europe
12 Middle East and Africa's Urinary Incontinence Device Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Nigeria
12.5 Qatar
12.6 Saudi Arabia
12.7 South Africa
12.8 United Arab Emirates
12.9 Rest of MEA
13 APAC's Urinary Incontinence Device Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific
14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
15 Company Profiles
15.1 A.M.I. GmbH
15.1.1 Company Overview
15.1.2 Company Snapshot
15.1.3 Product Overview
15.1.4 Business Overview
15.1.5 SWOT Analysis
15.1.6 Recent Developments
15.2 Aeroflow Urology
15.2.1 Company Overview
15.2.2 Company Snapshot
15.2.3 Product Overview
15.2.4 Business Overview
15.2.5 SWOT Analysis
15.2.6 Recent Developments
15.3 Axonics Modulation Technologies
15.3.1 Company Overview
15.3.2 Company Snapshot
15.3.3 Product Overview
15.3.4 Business Overview
15.3.5 SWOT Analysis
15.3.6 Recent Developments
15.4 B Braun Melsungen Ag
15.4.1 Company Overview
15.4.2 Company Snapshot
15.4.3 Product Overview
15.4.4 Business Overview
15.4.5 SWOT Analysis
15.4.6 Recent Developments
15.5 Baxter International, Inc.
15.5.1 Company Overview
15.5.2 Company Snapshot
15.5.3 Product Overview
15.5.4 Business Overview
15.5.5 SWOT Analysis
15.5.6 Recent Developments
15.6 Becton, Dickinson and Company
15.6.1 Company Overview
15.6.2 Company Snapshot
15.6.3 Product Overview
15.6.4 Business Overview
15.6.5 SWOT Analysis
15.6.6 Recent Developments
15.7 Boston Scientific Corp.
15.7.1 Company Overview
15.7.2 Company Snapshot
15.7.3 Product Overview
15.7.4 Business Overview
15.7.5 SWOT Analysis
15.7.6 Recent Developments
15.8 Caldera Medical, Inc.
15.8.1 Company Overview
15.8.2 Company Snapshot
15.8.3 Product Overview
15.8.4 Business Overview
15.8.5 SWOT Analysis
15.8.6 Recent Developments
15.9 Coloplast AS
15.9.1 Company Overview
15.9.2 Company Snapshot
15.9.3 Product Overview
15.9.4 Business Overview
15.9.5 SWOT Analysis
15.9.6 Recent Developments
15.10 ConvaTec Group PLC
15.10.1 Company Overview
15.10.2 Company Snapshot
15.10.3 Product Overview
15.10.4 Business Overview
15.10.5 SWOT Analysis
15.10.6 Recent Developments
15.11 Cook Group Inc.
15.11.1 Company Overview
15.11.2 Company Snapshot
15.11.3 Product Overview
15.11.4 Business Overview
15.11.5 SWOT Analysis
15.11.6 Recent Developments
15.12 Hollister, Inc.
15.12.1 Company Overview
15.12.2 Company Snapshot
15.12.3 Product Overview
15.12.4 Business Overview
15.12.5 SWOT Analysis
15.12.6 Recent Developments
15.13 Johnson & Johnson
15.13.1 Company Overview
15.13.2 Company Snapshot
15.13.3 Product Overview
15.13.4 Business Overview
15.13.5 SWOT Analysis
15.13.6 Recent Developments
15.14 Karl Storz SE & Co. KG
15.14.1 Company Overview
15.14.2 Company Snapshot
15.14.3 Product Overview
15.14.4 Business Overview
15.14.5 SWOT Analysis
15.14.6 Recent Developments
15.15 Laborie Medical
15.15.1 Company Overview
15.15.2 Company Snapshot
15.15.3 Product Overview
15.15.4 Business Overview
15.15.5 SWOT Analysis
15.15.6 Recent Developments
15.16 Medtronic PLC
15.16.1 Company Overview
15.16.2 Company Snapshot
15.16.3 Product Overview
15.16.4 Business Overview
15.16.5 SWOT Analysis
15.16.6 Recent Developments
15.17 Promedon Group
15.17.1 Company Overview
15.17.2 Company Snapshot
15.17.3 Product Overview
15.17.4 Business Overview
15.17.5 SWOT Analysis
15.17.6 Recent Developments
15.18 Teleflex, Inc.
15.18.1 Company Overview
15.18.2 Company Snapshot
15.18.3 Product Overview
15.18.4 Business Overview
15.18.5 SWOT Analysis
15.18.6 Recent Developments
15.19 UroMems
15.19.1 Company Overview
15.19.2 Company Snapshot
15.19.3 Product Overview
15.19.4 Business Overview
15.19.5 SWOT Analysis
15.19.6 Recent Developments
15.20 Zephyr Surgical Implants
15.20.1 Company Overview
15.20.2 Company Snapshot
15.20.3 Product Overview
15.20.4 Business Overview
15.20.5 SWOT Analysis
15.20.6 Recent Developments
16 Appendix
16.1 Self-Assessment Form

Companies Mentioned

  • A.M.I. GmbH
  • Aeroflow Urology
  • Axonics Modulation Technologies
  • B Braun Melsungen Ag
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corp.
  • Caldera Medical, Inc.
  • Coloplast AS
  • ConvaTec Group PLC
  • Cook Group Inc.
  • Hollister, Inc.
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Laborie Medical
  • Medtronic PLC
  • Promedon Group
  • Teleflex, Inc.
  • UroMems
  • Zephyr Surgical Implants

Table Information